Jazz Pharmaceuticals (JAZZ) Tops Q3 EPS by 26c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. INTC
2. AMZN
3. COIN
4. RDDT
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Jazz Pharmaceuticals (JAZZ) Tops Q3 EPS by 26c

Jazz Pharmaceuticals (JAZZ) PT Lowered to $200 at Cowen

November 7, 2018 8:57 AM EST

Cowen analyst Ken Cacciatore lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $200.00 (from $220.00) while maintaining a Outperform rating.

... More

Jazz Pharmaceuticals (JAZZ) PT Lowered to $203 at BMO Capital

November 7, 2018 8:56 AM EST

BMO Capital analyst Gary Nachman lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $203.00 (from $206.00) while maintaining a Outperform rating.

The analyst commented, "JAZZ reported mixed 3Q results with revenue of $469mm below BMO/consensus $478mm/$483mm, and adj. EPS of $3.58 ahead of... More

Jazz Pharmaceuticals (JAZZ) PT Lowered to $184 at RBC Capital

November 7, 2018 7:22 AM EST

RBC Capital analyst Randall Stanicky lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $184.00 (from $194.00) while maintaining a Outperform rating.

... More